- Home
- / Ikena Oncology
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Ikena Oncology financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$1.7
2024-10-29
Market Capitalization
$82.5 M
2024-10-29
Revenue
$800 K
FY, 2025
CreditSafe Score
?
Score changed on Jun 08, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|
| Revenue | 31.0M | 15.6M | 9.2M | 800.0K | |
| General and administrative expense | 18.0M | 22.2M | 24.9M | 23.7M | 20.7M |
| Operating expense total | 86.5M | 54.6M | 49.3M | ||
| EBIT | (34.1M) | (70.9M) | (75.4M) | (59.0M) | (48.5M) |
| EBIT margin, % | -454.0% | -6056.4% | |||
| Investment income | 7.4M | ||||
| Interest income | 2.1M | 7.1M | |||
| Interest expense | 2.0M | ||||
| Pre tax profit | (68.3M) | (49.1M) | (45.7M) | ||
| Income tax expense | (162.0K) | 152.0K | (350.0K) | ||
| Net Income | (34.1M) | (68.8M) | (68.2M) | (49.2M) | (45.3M) |
| EPS | (1.9) | (1.0) | (1.0) | (9.6) |